Preclinical and Translational Nuclear Medicine

Please find the overview outlined below.

EANM / Publications / Guidelines / Overview / Preclinical and Translational Nuclear Medicine

EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases

Erik H. J. G. Aarntzen, Edel Noriega-Álvarez, Vera Artiko, André H. Dias, Olivier Gheysens, Andor W. J. M. Glaudemans, Chiara Lauri, Giorgio Treglia, Tim van den Wyngaert, Fijs W. B. van Leeuwen & Samantha Y. A. Terry

read here September 6, 2021

Guidelines to PET measurements of the target occupancy in the brain for drug development

Akihiro Takano, Andrea Varrone, Balázs Gulyás, Piero Salvadori, Antony Gee, Albert Windhorst, Johnny Vercouillie, Guy Bormans, Adriaan A. Lammertsma & Christer Halldin

read here August 11, 2016

Guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

Sergio Todde, Albert D. Windhorst, Martin Behe, Guy Bormans, Clemens Decristoforo, Alain Faivre-Chauvet, Valentina Ferrari, Antony D. Gee, Balazs Gulyas, Christer Halldin, Petra Kolenc Peitl, Jacek Koziorowski, Thomas L. Mindt, Martina Sollini, Johnny Vercouillie, James R. Ballinger & Philip H. Elsinga

read here August 1, 2014

Guideline to Regulations for Radiopharmaceuticals in Early Phase Clinical Trials in the EU

Alfons Verbruggen, Heinz H. Coenen, Jean-Robert Deverre, Denis Guilloteau, Bengt Langstrom, Piero A. Salvadori & Christer Halldin

read here August 9, 2008